HeartSciences annual shareholders’ equity
2022
2023
2024
2025
2026
2026
HeartSciences Shareholders’ Equity Growth & History (HSCS)
HeartSciences's shareholders’ equity was $226,060 for fiscal 2026.
View full HeartSciences company overviewHeartSciences annual shareholders’ equity history
| Fiscal year | Period ended | Shareholders’ equity | Change | Growth |
|---|---|---|---|---|
| 2026 · Jun 30 | 2026-06-30 | $226,060 | — | — |
| 2026 · Apr 30 | 2026-04-30 | $226,060 | $20,889 | +10.18% |
| 2025 | 2025-04-30 | $205,171 | −$7.1M | −97.20% |
| 2024 | 2024-04-30 | $7.3M | $7.1M | +3073.75% |
| 2023 | 2023-04-30 | $230,557 | $6.3M | — |
| 2022 | 2022-04-30 | −$6.1M | — | — |
HeartSciences quarterly shareholders’ equity
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
Q4.26
Q4.26
| Fiscal quarter | Period ended | Shareholders’ equity | Change | YoY change |
|---|---|---|---|---|
| Q4 2026 · Jun 30 | 2026-06-30 | $226,060 | — | — |
| Q4 2026 · Apr 30 | 2026-04-30 | $226,060 | $20,889 | +10.18% |
| Q3 2026 | 2026-01-31 | $2.7M | $865,434 | +48.44% |
| Q2 2026 | 2025-10-31 | $4.2M | $165,749 | +4.13% |
| Q1 2026 | 2025-07-31 | $3.1M | −$2.8M | −47.07% |
| Q4 2025 | 2025-04-30 | $205,171 | −$7.1M | −97.20% |
| Q3 2025 | 2025-01-31 | $1.8M | −$6.8M | −79.31% |
| Q2 2025 | 2024-10-31 | $4.0M | $5.7M | — |
| Q1 2025 | 2024-07-31 | $5.9M | $6.5M | — |
| Q4 2024 | 2024-04-30 | $7.3M | $7.1M | +3073.75% |
| Q3 2024 | 2024-01-31 | $8.6M | $8.9M | — |
| Q2 2024 | 2023-10-31 | −$1.6M | −$2.7M | — |
| Q1 2024 | 2023-07-31 | −$519,702 | −$3.4M | — |
| Q4 2023 | 2023-04-30 | $230,557 | $6.3M | — |
| Q3 2023 | 2023-01-31 | −$257,912 | — | — |
| Q2 2023 | 2022-10-31 | $1.1M | — | — |
| Q1 2023 | 2022-07-31 | $2.9M | — | — |
| Q4 2022 | 2022-04-30 | −$6.1M | — | — |
HeartSciences shareholders’ equity trends
Between the periods ended 2022-04-30 and 2026-06-30, HeartSciences's shareholders’ equity increased from −$6.1M to $226,060, a change of $6.3M. The latest reported quarter, Q4 2026 · Jun 30, shows $226,060.
About the metric
What shareholders’ equity means
Shareholders’ equity is the residual accounting value attributable to shareholders after liabilities are subtracted from assets. It can change through earnings, losses, dividends, share issuance, repurchases, and other comprehensive income.
Calculation and source
SEC-reported shareholders’ equity
TickerStat standardizes stockholders’ or shareholders’ equity reported in company SEC filings at each balance-sheet date. Negative equity is retained because it can be economically meaningful. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review HeartSciences source filings ↗